Longeveron Inc. (LGVN) NASDAQ

$3.76 -0.18 (-4.57%)

Market Cap: $23.35M

As of 12/02/22 04:00 PM EST. Market closed.

(LGVN)

Longeveron Inc. (LGVN) NASDAQ

$3.76 -0.18 (-4.57%)

Market Cap: $23.35M

As of 12/02/22 04:00 PM EST. Market closed.

Longeveron is a clinical stage biotechnology company developing cellular therapies for specific aging-related and life-threatening conditions. The Company’s lead investigational product is the LOMECEL-B™ cell-based therapy product ("Lomecel-B"), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young, healthy adult donors. Longeveron ... read more

Longeveron is a clinical stage biotechnology company developing cellular therapies for specific aging-related and life-threatening conditions. The Company’s lead investigational product is the LOMECEL-B™ cell-based therapy product ("Lomecel-B"), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young, healthy adult donors. Longeveron believes that by using the same cells that promote tissue repair, organ maintenance, and immune system function, it can develop safe and effective therapies for some of the most difficult disorders associated with the aging process and other medical disorders. Longeveron is currently sponsoring Phase 1 and 2 clinical trials in the following indications: Aging Frailty, Alzheimer’s disease, the Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and hypoplastic left heart syndrome (HLHS). The Company’s mission is to advance Lomecel-B and other cell-based product candidates into pivotal Phase 3 trials, with the goal of achieving regulatory approvals, subsequent commercialization and broad use by the healthcare community. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
12
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$3.82
Previous Close
$3.94
Days Range
$3.65 - $3.92
52 week range
$3.15 - $26
Volume
111,333
Avg. Volume (30 days)
93,356
Market Cap
$23.35M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
5,925,935
Open
$3.82
Previous Close
$3.94
Days Range
$3.65 - $3.92
52 week range
$3.15 - $26
Volume
111,333
Avg. Volume (30 days)
93,356
Market Cap
$23.35M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
5,925,935

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR LONGEVERON INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Hare Joshua Chief Scientific Officer Oct 12, 2022 Sale $3.61 100,000 361,000 7,813,263 Oct 18, 2022, 05:01 PM
Clavijo James CFO and Treasurer Oct 03, 2022 Option Exercise $3.75 1,256 4,710 76,937 Oct 05, 2022, 05:01 PM
Lehr Paul T General Counsel, Secretary Oct 03, 2022 Option Exercise $3.75 1,435 5,381 148,514 Oct 05, 2022, 05:00 PM
Clavijo James CFO and Treasurer Jul 01, 2022 Option Exercise $5.94 1,426 8,470 78,193 Jul 05, 2022, 05:01 PM
Lehr Paul T General Counsel, Secretary Jul 01, 2022 Option Exercise $5.94 1,629 9,676 149,949 Jul 05, 2022, 05:00 PM
Clavijo James CFO and Treasurer Jun 03, 2022 Sale $8.26 36,955 305,248 79,619 Jun 07, 2022, 05:00 PM
Soffer Rock Director May 24, 2022 Sale $7.50 4,000 30,000 672,351 May 24, 2022, 05:14 PM
Soffer Rock Director May 23, 2022 Sale $7.78 8,000 62,200 676,351 May 24, 2022, 05:14 PM
Soffer Rock Director May 20, 2022 Sale $8.06 7,500 60,435 684,351 May 24, 2022, 05:14 PM
Hare Joshua Chief Scientific Officer Apr 19, 2022 Sale $10.00 78 780 7,913,263 Apr 20, 2022, 05:00 PM
Hare Joshua Chief Scientific Officer Apr 18, 2022 Sale $10.00 19,922 199,290 7,913,341 Apr 20, 2022, 05:00 PM
Lehr Paul T General Counsel, Secretary Apr 04, 2022 Option Exercise $15.61 1,472 22,978 111,578 Apr 08, 2022, 05:00 PM
Green Geoff CEO Apr 04, 2022 Option Exercise $15.61 1,840 28,722 133,904 Apr 08, 2022, 05:00 PM
Hare Joshua Chief Scientific Officer Oct 12, 2021 Buy $3.69 2,500 9,225 7,933,263 Oct 14, 2021, 09:00 AM
Green Geoff CEO Oct 13, 2021 Buy $3.81 1,000 3,810 139,723 Oct 14, 2021, 09:00 AM
Soffer Rock Director Oct 12, 2021 Buy $3.57 4,000 14,280 39,757 Oct 13, 2021, 06:00 PM
Soffer Rock Director Oct 11, 2021 Buy $3.45 3,900 13,455 35,757 Oct 13, 2021, 06:00 PM
Soffer Rock Director Oct 13, 2021 Buy $3.76 12,000 45,120 51,757 Oct 13, 2021, 06:00 PM
Clavijo James CFO and Treasurer Oct 07, 2021 Buy $3.34 5,000 16,700 79,598 Oct 12, 2021, 09:30 AM
Lehr Paul T General Counsel, Secretary Oct 07, 2021 Buy $3.34 1,750 5,845 116,366 Oct 12, 2021, 09:30 AM
Hare Joshua Chief Scientific Officer Oct 08, 2021 Buy $3.39 3,015 10,221 7,930,763 Oct 12, 2021, 09:30 AM
Hare Joshua Chief Scientific Officer Oct 07, 2021 Buy $3.38 1,985 6,709 7,927,748 Oct 12, 2021, 09:30 AM
Lehr Paul T General Counsel, Secretary Oct 01, 2021 Option Exercise $3.65 38,752 141,445 114,616 Oct 01, 2021, 08:01 PM
Clavijo James CFO and Treasurer Oct 01, 2021 Option Exercise $3.65 19,052 69,540 74,598 Oct 01, 2021, 08:00 PM
Green Geoff CEO Oct 01, 2021 Option Exercise $3.65 43,929 160,341 138,723 Oct 01, 2021, 08:00 PM
Hare Joshua Chief Scientific Officer Feb 12, 2021 Buy $10.00 12,000 120,000 7,908,428 Apr 09, 2021, 04:03 PM
Soffer Rock Director Feb 12, 2021 Buy $8.05 100 805 26,857 Feb 26, 2021, 06:00 PM
Soffer Donald M Director Feb 12, 2021 Buy $10.00 100,000 1,000,000 153,514 Feb 26, 2021, 06:00 PM
Hare Joshua Chief Scientific Officer Feb 12, 2021 Buy $9.98 103,000 1,028,230 7,998,428 Feb 17, 2021, 04:30 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Hare Joshua Chief Scientific Officer 10/12/2022 361,000
Clavijo James CFO and Treasurer 10/03/2022 4,710
Lehr Paul T General Counsel, Secretary 10/03/2022 5,381
Clavijo James CFO and Treasurer 07/01/2022 8,470
Lehr Paul T General Counsel, Secretary 07/01/2022 9,676
Clavijo James CFO and Treasurer 06/03/2022 305,248
Soffer Rock Director 05/24/2022 30,000
Soffer Rock Director 05/23/2022 62,200
Soffer Rock Director 05/20/2022 60,435
Hare Joshua Chief Scientific Officer 04/19/2022 780
Hare Joshua Chief Scientific Officer 04/18/2022 199,290
Lehr Paul T General Counsel, Secretary 04/04/2022 22,978
Green Geoff CEO 04/04/2022 28,722
Hare Joshua Chief Scientific Officer 10/12/2021 9,225
Green Geoff CEO 10/13/2021 3,810
Soffer Rock Director 10/12/2021 14,280
Soffer Rock Director 10/11/2021 13,455
Soffer Rock Director 10/13/2021 45,120
Clavijo James CFO and Treasurer 10/07/2021 16,700
Lehr Paul T General Counsel, Secretary 10/07/2021 5,845
Hare Joshua Chief Scientific Officer 10/08/2021 10,221
Hare Joshua Chief Scientific Officer 10/07/2021 6,709
Lehr Paul T General Counsel, Secretary 10/01/2021 141,445
Clavijo James CFO and Treasurer 10/01/2021 69,540
Green Geoff CEO 10/01/2021 160,341
Hare Joshua Chief Scientific Officer 02/12/2021 120,000
Soffer Rock Director 02/12/2021 805
Soffer Donald M Director 02/12/2021 1,000,000
Hare Joshua Chief Scientific Officer 02/12/2021 1,028,230
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2022
12/31/2021
10.64%
2Q
06/30/2022
06/30/2021
14.66%
4Q

Period of Report: 06/30/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2021
10.64%
2Q
06/30/2021
14.66%
4Q